Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon
Chao Chen,1 Ning Wu,2 Crystal Watson2 1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA; 2Value and Access, Biogen, Cambridge, MA, USA Background: Real-world outcomes from staying on an interferon beta (IFNβ) vs switching to anoth...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/multiple-sclerosis-patients-who-are-stable-on-interferon-therapy-show--peer-reviewed-article-CEOR |